+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

PALFORZIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PALFORZIA Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Global Endometriosis Pain - Pipeline Insight, 2022 - Product Thumbnail Image

Global Endometriosis Pain - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
From
Food Allergy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Food Allergy - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 72 Pages
  • Global
From
From
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 280 Pages
  • Global
From
LAG-3 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 96 Pages
  • Global
From
From
TIGIT inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

TIGIT inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CD47 antigen inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

CD47 antigen inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 200 Pages
  • Global
From
Toll-Like Receptor Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
4-1BB receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

4-1BB receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Interleukin-12 expression stimulants - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-12 expression stimulants - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CD137 Agonist Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

CD137 Agonist Antibody - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more